Skip to main content

Alpa Laboratories Ltd

NSE: ALPA BSE: 532878

Alpa Laboratories Ltd (ALPA) is a Diversified company listed on NSE: ALPA | BSE: 532878. With a market cap of ₹146 Cr and ROCE of 15%, ROE of 11.5%, it operates in the Indian Diversified sector.

69.2
52W: ₹46 — ₹120
PE 12.4 · Book ₹92 · -25% vs book
Market Cap₹146 Cr
Stock P/E12.4Price to Earnings
ROCE15%Return on Capital
ROE11.5%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company has reduced debt.
  • +Company is almost debt free.
  • +Stock is trading at 0.76 times its book value
  • +Company has delivered good profit growth of 29.6% CAGR over last 5 years

Weaknesses

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 5.24% over past five years.
  • Company has a low return on equity of 10.7% over last 3 years.
  • Earnings include an other income of Rs.19.2 Cr.
  • Company has high debtors of 155 days.

Shareholding Pattern

Promoters57.19%
FIIs0.38%
DIIs0%
Public42.43%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters57.29%57.29%57.29%57.29%57.29%57.29%57.29%57.19%0.1
FIIs0.36%0.74%0.40.35%0.40.4%0.10.36%0.00.35%0.00.36%0.00.38%0.0
DIIs0%0%0%0%0%0%0%0%
Public42.35%41.97%0.442.34%0.442.3%0.042.34%0.042.36%0.042.35%0.042.43%0.1

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales32.3927.3123.6121.4424.9426.1539.1119.1125.6329.67
Expenses29.0724.8520.120.921.6725.4139.4718.6928.527.53
Operating Profit3.322.463.510.543.270.74-0.360.42-2.872.14
OPM %10.25%9.01%14.87%2.52%13.11%2.83%-0.92%2.2%-11.2%7.21%
Net Profit5.744.533.555.127.638.89-1.9511.780.11.87
EPS ₹2.732.151.692.433.634.23-0.935.60.050.89

AI Insights

Revenue Trend

TTM revenue at ₹114Cr, up 3.6% YoY. OPM at -1%.

Debt Position

Borrowings at ₹2Cr. Debt-to-equity ratio: 0.01x. Healthy balance sheet.

Institutional Flow

DIIs: 0% (-0.01pp change). FIIs: 0.38% (+0.38pp change). Promoters hold 57.19%.

Margin & Efficiency

ROCE improving from -3% (Mar 2014) to 15% (Mar 2025). Working capital days: 108.

Valuation

PE 12.4x with 15% ROCE. Price is -25% above book value of ₹92. Dividend yield: 0%.

Recent Announcements